Gene Amplification Technologies Market Future Trends With Research 2028
Gene Amplification Technologies Industry Overview
The global gene amplification technologies market size was valued at USD 26.28 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 2.0% from 2021 to 2028.
The growing need for research and development in the field of molecular diagnostics, genomics, biological research, and genetic testing is a key factor fueling market growth. The constant development of numerous diagnostic tests based on various gene amplification methods for COVID-19 has further driven the market. A PCR-based diagnostic test is considered to be the gold standard approach for the detection of SARS-CoV-2 infection. Several product launches and technological advancements by the key players are expected to provide sensitive and rapid diagnosis of COVID-19 at POC settings.
Gather more insights about the market drivers, restrains and growth of the Global Gene Amplification Technologies Market

The constantly expanding landscape of advanced DNA multiplication technologies is one of the key driving forces of the market. Owing to the technological advancements concerning loop-mediated amplification, substitutes and advanced technologies such as Nucleic Acid Sequence Based Amplification (NASBA), Rolling Circle Amplification (RCA), and Loop-Mediated Isothermal Amplification (LAMP) have been extensively studied.
These techniques are witnessing increased traction owing to their advantages such as no requirement of expensive thermal cyclers, rapid amplification kinetics, and easy multiplication from a single cell. These factors are expected to propel the usage of products offered in this market and thereby augment the organic revenue generation.
The applicability of gene amplification and vector engineering is increasing the demand for gene amplification assays. Moreover, the usage of gene amplification technologies for revolutionizing the diagnosis of inherited, infectious, and systemic diseases is anticipated to increase revenue growth in the sector.
Browse through Grand View Research's Biotechnology Industry Research Reports.
- Molecular Diagnostics Market - The global molecular diagnostics market size was valued at USD 37.04 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of -1.6% from 2022 to 2030.
- Genomics Market - The global genomics market size was valued at USD 20.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.35% from 2021 to 2028.
Market Share Insights
- July 2021: BioGX was granted the EUA for its Xfree COVID-19 test by the U.S. FDA. This is a high-throughput, RT-PCR test kit.
- April 2021: Hologic acquired the Finnish-French molecular test maker - Mobidiag to cope up with the growing COVID-19 diagnostic demand.
- April 2021: Chinese researchers developed an ultrasensitive and rapid ELISA test based on rolling circle amplification for the early diagnosis of various diseases.
- January 2021: Luna SARS-CoV-2 RT-qPCR Assay Kit was introduced by New England BioLabs, Inc. (Massachusetts, U.S.) for the detection of SARS-CoV-2 nucleic acid.
Key Companies profiled:
Some prominent players in the global gene amplification technologies market include
- QIAGEN
- New England Biolabs
- Illumina Inc.
- Yikang Gene
- Bio-Rad Laboratories
- Silicon Biosystems
- Merck KGaA
- Promega Corporation
- Takara Bio Inc.
- Danaher Corporation
- 4basebio AG
- LGC Group
- Vazyme Biotech Co. Ltd.
- MyBioSource
Order a free sample PDF of the Gene Amplification Technologies Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment